EUVIMEDEUVIMED entdecken
Klinische Studie

Coronary Sinus Narrowing for the Treatment of Patients With Angina and Evidence of Microvascular Dysfunction: A Prospective Single-Arm Study

Maayan Konigstein, Itamar Loewenstein, Ophir Freund, Jeremy Ben-Shoshan, Yishay Szekely, Miri Revivo, Keith Jackson, Shmuel Banai

Canadian Journal of Cardiology · 2026-11 · 42 (11) · 2710-2718

DOI: 10.1016/j.cjca.2026.05.025 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Canadian Journal of Cardiology, 2026-11. Verfasst von Maayan Konigstein und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel A…. Hauptthemen laut MEDLINE: Angina Pectoris, Coronary Circulation, Coronary Sinus, Microcirculation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Angina caused by coronary microvascular dysfunction (CMD) represents a particularly challenging clinical scenario. Coronary sinus Reducer (Shockwave Medical, Santa Clara, CA) implantation is a safe and effective therapy for patients with refractory angina and obstructive coronary artery disease. We evaluated the efficacy of Reducer implantation in patients with angina and CMD on microvascular function parameters, angina severity, functional capacity, and quality of life (QoL). METHODS: Patients with refractory angina, nonobstructive coronary artery disease, and evidence of CMD underwent Reducer implantation. Invasive evaluation of microvascular function, including index of microcirculatory resistance, coronary flow reserve, resistive reserve ratio, and microvascular resistance reserve was performed at baseline and 4 months after Reducer implantation. Angina symptoms, functional capacity, and QoL were evaluated using the Canadian Cardiovascular Society class, 6-minute walk test, and Seattle Angina Questionnaire, respectively, at baseline and 4 months after Reducer implantation. RESULTS: Forty patients (median age, 68 years [interquartile range (IQR), 59-77 years]; 55% female) were included. At 4 months, median index of microcirculatory resistance decreased (35 [IQR, 25-43] to 17 [IQR, 10-32]; P < 0.001), median coronary flow reserve increased (1.6 [IQR, 1.3-2.0] to 2.8 [IQR, 1.9-3.3]; P < 0.001), median resistive reserve ratio increased (1.9 [IQR, 1.7-2.3] to 2.9 [IQR, 2.0-3.7]; P < 0.001), and median microvascular resistance reserve increased (2.1 [IQR, 1.7-2.5] to 3.3 [IQR, 2.3-4.0]; P < 0.001). Canadian Cardiovascular Society class improved from a median of III to II, alongside significant improvements in 6-minute walk test median distance (300 [IQR, 231-400] to 383 [IQR, 278-452] m; P < 0.001) and all 5 Seattle Angina Questionnaire domains (P < 0.05 for all). CONCLUSIONS: Reducer implantation significantly improved coronary microvascular function, angina symptoms, functional capacity, and QoL in patients with angina and evidence of microvascular dysfunction. CLINICAL TRIAL REGISTRATION: MOH_2020-04-05_008834 at https://clinicaltrial.health.gov.il/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angina PectorisCoronary CirculationCoronary SinusMicrocirculationAgedFemaleHumansMaleMiddle AgedCoronary AngiographyFollow-Up StudiesProspective StudiesQuality of LifeTreatment OutcomeVascular Resistance

Stichwörter der Autor:innen

Coronary sinus Reduceranginaangina with nonobstructive coronary arteriescoronary physiologymicrovascular dysfunctionquality of life

Autor:innen und Institutionen

  • Department of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: maayan.konigstei…
  • Department of Cardiology, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Pulmonary Medicine, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel.
  • Shockwave Medical Inc, Santa Clara, California, USA.

Zitieren

APA

Konigstein, M., Loewenstein, I., Freund, O., Ben-Shoshan, J., Szekely, Y., Revivo, M., Jackson, K., & Banai, S. (2026). Coronary Sinus Narrowing for the Treatment of Patients With Angina and Evidence of Microvascular Dysfunction: A Prospective Single-Arm Study. Canadian Journal of Cardiology, 42(11), 2710-2718. https://doi.org/10.1016/j.cjca.2026.05.025

Vancouver

Konigstein M, Loewenstein I, Freund O, Ben-Shoshan J, Szekely Y, Revivo M, et al. Coronary Sinus Narrowing for the Treatment of Patients With Angina and Evidence of Microvascular Dysfunction: A Prospective Single-Arm Study. Canadian Journal of Cardiology. 2026;42(11):2710-2718. doi:10.1016/j.cjca.2026.05.025

BibTeX
@article{Konigstein2026,
  author = {Konigstein, Maayan and Loewenstein, Itamar and Freund, Ophir and Ben-Shoshan, Jeremy and Szekely, Yishay and Revivo, Miri and Jackson, Keith and Banai, Shmuel},
  title = {Coronary Sinus Narrowing for the Treatment of Patients With Angina and Evidence of Microvascular Dysfunction: A Prospective Single-Arm Study},
  journal = {Canadian Journal of Cardiology},
  year = {2026},
  volume = {42},
  number = {11},
  pages = {2710--2718},
  doi = {10.1016/j.cjca.2026.05.025}
}
Kostenlos starten →